Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indomethacin for prevention of post-ERCP acute pancreatitis
RBR-5g7hghvCompleted
- Sponsor
- Santa Casa de Porto Alegre
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) and acute pancreatitis (AP) (3 arms), sponsored by Santa Casa de Porto Alegre. Started Apr 2020; status: completed.
02
Drugs
indomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)acute pancreatitis (AP)
Beyond the preview
Go deeper on RBR-5g7hghv.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5g7hghv.